Wenzhou Medical University
🇨🇳China
Clinical Trials
94
Active:4
Completed:39
Trial Phases
5 Phases
Phase 1:2
Phase 2:3
Phase 3:3
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (53 trials with phase data)• Click on a phase to view related trials
Not Applicable
43 (81.1%)Phase 2
3 (5.7%)Phase 3
3 (5.7%)Phase 1
2 (3.8%)Phase 4
2 (3.8%)Comparing Monofocal IOLs in Highly Myopic Cataract Patients
Not yet recruiting
- Conditions
- Cataract
- First Posted Date
- 2025-04-02
- Last Posted Date
- 2025-04-02
- Lead Sponsor
- Wenzhou Medical University
- Target Recruit Count
- 60
- Registration Number
- NCT06905938
- Locations
- 🇨🇳
Ophthalmology and Optometry Hos, Hanzhou, zhejian, China
Visual Quality of Cataract Patients with High Myopia After Implantation of Different Intraocular Lenses
Active, not recruiting
- Conditions
- Cataract
- First Posted Date
- 2025-03-24
- Last Posted Date
- 2025-03-24
- Lead Sponsor
- Wenzhou Medical University
- Target Recruit Count
- 62
- Registration Number
- NCT06892470
- Locations
- 🇨🇳
Ophthalmology and Optometry Hos, Hanzhou, zhejian, China
Using Psychophysics Methods to Investigate Sensory Dominance After Cataract Surgery
Active, not recruiting
- Conditions
- Cataract
- First Posted Date
- 2024-12-27
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- Wenzhou Medical University
- Target Recruit Count
- 96
- Registration Number
- NCT06751342
- Locations
- 🇨🇳
Ophthalmology and Optometry Hospital, Wenzhou, Wenzhou, Zhejiang, China
Comparison of the Effect of Capsular Bend on the Rotational Stability Between Two Toric Intraocular Lenses
Active, not recruiting
- Conditions
- Cataract
- First Posted Date
- 2024-11-27
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- Wenzhou Medical University
- Target Recruit Count
- 68
- Registration Number
- NCT06707740
- Locations
- 🇨🇳
Ophthalmology and Optometry Hospital, Wenzhou, Wenzhou, China
Quantitative Assessment of Lid Margin Vascularity Using SS-OCTA
Not yet recruiting
- Conditions
- Lid Margin Blood Flow DensitySs-octaMGD
- First Posted Date
- 2023-10-19
- Last Posted Date
- 2023-10-19
- Lead Sponsor
- Wenzhou Medical University
- Target Recruit Count
- 150
- Registration Number
- NCT06091722
- Prev
- 1
- 2
- 3
- 4
- 5
- 19
- Next
News
FDA Grants Orphan Drug Designation to China-Developed ApDC for Uveal Melanoma
An Aptamer Drug Conjugate (ApDC) developed by Chinese researchers has received orphan drug designation from the FDA for uveal melanoma treatment.